Research location
Søborg
Denmark
Advertisement
Research activity in Søborg
DenmarkCureCurrent currently publishes aggregate city-level research activity for this location: 11 trials and 11 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Søborg
11 linked trials · page 1 of 1PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)NCT07263490 · 2024-10-21 · 1 site observation
RECRUITING
Intensive Weight Loss Intervention Versus Usual Care for Adults With ObesityNCT06321432 · 2024-06-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Intensive Weight Loss Intervention Versus Usual Care for Adults With Severe and Complex ObesityNCT06321458 · 2024-04-29 · 1 site observation
ACTIVE_NOT_RECRUITING
Patient Preference Study in Type-2 Diabetes Mellitus: Discrete Choice Experiment (DCE) to Support Novo Nordisk's Long-Acting InsulinNCT06592950 · 2023-11-02 · 1 site observation
COMPLETED
A Research Study of a New Medicine NNC0519-0130 in Healthy People, People With High Body Weight and People With Type 2 Diabetes.NCT05363774 · 2022-04-20 · 1 site observation
COMPLETED
A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Combined Versus Separate Injections in People With Overweight or ObesityNCT04940078 · 2021-07-07 · 1 site observation
COMPLETED
Reduced COPD Related Utilization of Healthcare Services and Increased Social Activities by Patients Offered a 24/7 Accessible Telehealth Service Based on the Epital Care Model.NCT06988566 · 2020-09-04 · 1 site observation
COMPLETED
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Denmark, as Part of Local Clinical PracticeNCT04537637 · 2020-08-28 · 1 site observation
COMPLETED
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Denmark and Sweden, as Part of Local Clinical Practice (SURE DENMARK/SWEDEN)NCT03648281 · 2018-08-24 · 1 site observation
COMPLETED
Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD RegimenNCT01985334 · 2014-02-14 · 1 site observation
COMPLETED
Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Using Salmeterol as Active ControlNCT00567996 · 2007-11-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.